French court finds Pharma negligent in diabetes drug controversy
A French court has determined a pharmaceutical company was negligent in a scandal over a diabetes drug linked to multiple deaths.
FDA reviews new interpretation of study on Avandia risks
The FDA is set to weigh in on lifting safety restrictions on the diabetes drug Avandia.